Technology-Enabled Collaborative Care for Diabetes and Mental Health
TECC-DM
Bridging Gaps, Enhancing Wellbeing: Examining the Effectiveness of the Technology-Enabled Collaborative Care for Diabetes and Mental Health (TECC-DM) Model
1 other identifier
interventional
160
1 country
1
Brief Summary
Managing both type 2 diabetes and mental health challenges can be difficult, and many people do not receive care that supports both. This study looks at how virtual health coaching and support from interdisciplinary care teams can help people better manage their health. The purpose of this study is to test the effectiveness of a virtual health coaching program for adults living with type 2 diabetes and mental health challenges compared to usual care. The Technology-Enabled Collaborative Care for type 2 Diabetes and Mental health (TECC-DM) program includes weekly coaching calls, support from an interdisciplinary care team, and online tools to aid self-management. The findings from this study will be used to help improve services for people who have type 2 diabetes and co-occurring mental health symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes
Started Mar 2025
Typical duration for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2025
CompletedFirst Submitted
Initial submission to the registry
September 8, 2025
CompletedFirst Posted
Study publicly available on registry
September 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
April 2, 2026
September 1, 2025
2.7 years
September 8, 2025
March 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life
Quality of life refers to an individual's overall well-being, encompassing physical, mental, emotional, and social dimensions of health. In this study, it is measured using the EuroQol-5D (EQ-5D), which captures participants' perceptions of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Unit of Measure: EQ-5D-5L index score. Minimum Value: 0 (the worst possible health state). Maximum Value: 100 (the best possible health state). Interpretation: Higher scores indicate better health-related quality of life.
From baseline to 12 weeks post-intervention and at 6-month follow-up
Secondary Outcomes (6)
Change in diabetes distress score (Diabetes Distress Scale, DDS)
From baseline to 12 weeks post-intervention and at 6-month follow-up
Change in psychological and behavioural health symptoms (Global Appraisal of Individual Needs Short Screener, GAIN-SS)
From baseline to 12 weeks post-intervention and at 6-month follow-up
Change in perceived stress score (Perceived Stress Scale, PSS)
From baseline to 12 weeks post-intervention and at 6-month follow-up
Change in depressive symptoms (Patient Health Questionnaire, PHQ-9)
From baseline to 12 weeks post-intervention and at 6-month follow-up
Change in diabetes self-management (Diabetes Self-Management Questionnaire, DSMQ)
From baseline to 12 weeks post-intervention and at 6-month follow-up
- +1 more secondary outcomes
Study Arms (2)
TECC-DM model
EXPERIMENTALParticipants (n=80) are randomized to the TECC-DM arm, a 12-week, relation-driven and integrated model of care delivered virtually in addition to usual diabetes care. Weekly 1-hour sessions with a health coach are supported by guidance from an interdisciplinary virtual care team, using phone, text, Zoom, and REDCap. The program follows a structured protocol to ensure fidelity. TECC-DM is designed to improve quality of life (primary outcome) and goals of care (secondary outcomes: mental health, self-management, and physiological indicators).
Educational emails
ACTIVE COMPARATORParticipants (n=80) receive usual diabetes care, which may include primary or specialist care and community-based supports, with services documented to capture variation. In addition, participants receive 10 standardized educational emails over 12 weeks. This arm provides a structured, fidelity-monitored comparison to TECC-DM.
Interventions
Health coaching is the active component of TECC-DM. In weekly 1-hour sessions, the coach builds a therapeutic relationship, supports goal-setting and behaviour change, addresses mental health needs, coordinates resources, and empowers participants to navigate care. Coaching is delivered according to a standardized protocol, in consultation with the virtual care team, and targets improvements in quality of life and goals of care. Coaches do not provide pharmacological treatment or replace usual diabetes care.
Participants receive usual diabetes care (e.g., primary care, endocrinology, community supports) plus 10 standardized educational emails over 12 weeks, delivered according to a consistent protocol. Unlike TECC-DM, this approach does not involve a therapeutic relationship, health coach, or interdisciplinary care team.
Eligibility Criteria
You may qualify if:
- Adults ≥18 years old
- Diagnosed with type 2 diabetes (T2D)
- Experiencing mental health challenges, defined as:
- Hospital Anxiety and Depression Scale (HADS) score ≥8 on either subscale OR
- Diabetes Distress Scale (DDS) score ≥2
- Community-living
- Able to communicate verbally in English
- Residing in Ontario during study participation
You may not qualify if:
- Diagnosis of severe mental illness (e.g., schizophrenia, psychotic disorder)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Diabetes Canadacollaborator
- McMaster Universitylead
- Centre for Addiction and Mental Healthcollaborator
Study Sites (1)
McMaster University
Hamilton, Ontario, L8S 4K1, Canada
Related Publications (2)
Vojtila L, Sherifali D, Dragonetti R, Ashfaq I, Veldhuizen S, Naeem F, Agarwal SM, Melamed OC, Crawford A, Gerretsen P, Hahn M, Hill S, Kidd S, Mulsant B, Serhal E, Tackaberry-Giddens L, Whitmore C, Marttila J, Tang F, Ramdass S, Lourido G, Sockalingam S, Selby P. Technology-Enabled Collaborative Care for Concurrent Diabetes and Distress Management During the COVID-19 Pandemic: Protocol for a Mixed Methods Feasibility Study. JMIR Res Protoc. 2023 Jan 17;12:e39724. doi: 10.2196/39724.
PMID: 36649068BACKGROUNDSherifali D, Whitmore C, Naeem F, Melamed OC, Dragonetti R, Kouzoukas E, Marttila J, Tang F, Tanzini E, Ramdass S, Selby P. Technology-Enabled Collaborative Care for Type-2 Diabetes and Mental Health (TECC-D): Findings From a Mixed Methods Feasibility Trial of a Responsive Co-Designed Virtual Health Coaching Intervention. Int J Integr Care. 2024 Feb 16;24(1):12. doi: 10.5334/ijic.7608. eCollection 2024 Jan-Mar.
PMID: 38370569BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carly Whitmore, RN PhD
McMaster University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 8, 2025
First Posted
September 18, 2025
Study Start
March 16, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
April 2, 2026
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to the sensitive nature of health and mental health information, the risk of re-identification, and ethical requirements under local privacy legislation and research ethics board approvals. Aggregated data may be available upon reasonable request.